The secret to reducing staff turnover
April 15th 2017Is staff turnover holding you back? In some markets, healthcare personnel turnover is five times higher than unemployment. The average total turnover rate reported for healthcare employers in 2016 is 20.1%, up from 19.2% in 2015, according to Compdata Surveys’ national survey, Compensation Data Healthcare.
Cataract, glaucoma surgery in uveitis patients present added challenges
April 15th 2017Cataract surgery in patients with coexisting uveitis is more challenging than managing either condition alone. Surgeons must answer a different set of questions and consider alternative management strategies, said Debra A. Goldstein, MD, FRSC, professor of ophthalmology and director of the Uveitis Service, Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago.
New IOL category offers more natural range of vision
April 14th 2017There are a number of ways to improve near vision for presbyopes, including multifocal intraocular lenses (IOLs)–traditional or low add–and pseudoaccommodative IOLs. It has been well documented that a small pupil and higher order aberrations, such as spherical aberration (SA) or coma, can increase depth of focus.
New paradigm shift in selecting a steroid course prior to FAc implant
April 8th 2017As retinal specialists, we are truly fortunate to live in a time where we have several treatment options for patients with diabetic macular edema (DME). A fluocinolone acetonide (FAc) intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in IOP.
Dr. William Tasman, former Wills Eye ophthalmologist-in-chief, dies
April 1st 2017Wills Eye Hospital’s “powerhouse” William Tasman, MD, passed away March 28, 2017, at the age of 87. In the same short period, the retinal world had another sad passing of Eliot L. Berson, MD, on March 19, 2017 at the age of 79.
Blocked clinic flow can be analogous to a beaver dam
April 1st 2017Meaningful use and government mandates have added blocks all throughout the system that continue to add more and more time to each patient visit--and ends up damming up the clinic from ever getting their hands on the patient to do the exam.
Does FLACS cost, benefit outweigh manual? Yes!
April 1st 2017Though further study is needed to determine conclusively whether or not femtosecond laser-assisted cataract surgery (FLACS) is associated with better refractive outcomes compared with conventional manual surgery, FLACS offers many other benefits that justify its use, according to Robert J. Cionni, MD.
Does FLACS cost, benefit outweigh manual? No!
April 1st 2017Femtosecond laser-assisted cataract surgery (FLACS) offers some advantages compared with a conventional manual procedure, particularly for certain patients. Currently, however, FLACS does not result in superior outcomes and it has drawbacks that outweigh its benefits, according to Rosa Braga-Mele, MD.
Study: Visual acuity outcomes similar, but FLACS has some advantages
April 1st 2017Femtosecond laser-assisted cataract surgery (FLACS) facilitated a precise capsulotomy and reduced phaco energy in a recent ongoing study with about 100 consecutive eyes, said Jeffrey Whitman, MD, Key-Whitman Eye Center, Dallas.
Redesigned pupil expansion device reduces cataract surgery risks
April 1st 2017Pre-treatment with the femtosecond laser in eyes undergoing cataract surgery can induce miosis. The use of a pupil expansion device, however, offers an effective method for managing small pupils in femtosecond laser-assisted cases whether the problem pre-exists or is caused by the laser, said Boris Malyugin, MD, PhD.
How pattern, flicker ERG can impact cataract treatment decisions
April 1st 2017Retinal issues can impact cataract surgery outcomes, especially for those with multifocal or other premium lenses. While multifocal lenses may allow the patient to see more clearly across a range of distances, they may also decrease the amount of light that reaches the retina, exacerbating any issues that may already be present.
How conference attendance benefits your team
March 21st 2017Are you planning on going to a conference this year? As Howard Schultz, chairman and chief executive officer of Starbucks, summarized, knowledge and skill are your keys to earning more. Professional conference season is upon us. Which ones are you paying for you and your employees to attend? No matter how dedicated and organized your practice may be, it’s impossible to internally train each and every staff member to the high level of excellence your patients demand. Thoughtfully motivating and engaging employees takes a concerted and systemic approach to learning and skills training.
Lifitegrast data support dry eye efficacy over placebo drops
March 15th 2017Lifitegrast ophthalmic solution 0.05% (Xiidra, Shire) has demonstrated positive results for the treatment of the signs and symptoms of dry eye disease. Eye dryness scores for some patients have improved after two weeks of treatment with the topical drop.
Non-invasive punctal plug delivery system offers a host of positive performance characteristics
March 15th 2017A silicone punctal plug-based delivery system for ophthalmic medications (Evolute, Mati Therapeutics) provides precisely controlled medication release into the tear film and has been associated with positive results in initial clinical testing.
Protein agent may change approach to treating dry eye, inflammation
March 15th 2017Recombinant human lubricin showed potential as a new therapeutic approach to the management of dry eye disease in a small clinical trial. Compared with sodium hyaluronate, lubricin (Lubris BioPharma), significantly improved both signs and symptoms of moderate dry eye after two weeks of treatment.
Novel topical peptide for dry eye tackles underlying cause of disease
March 15th 2017A phase I/II trial enrolling patients with Sjögrens syndrome dry eye will be investigating a synthetic fragment of a naturally occurring tear glycoprotein. Findings from extensive laboratory and preclinical research suggest that it is a promising novel therapy.